INOVIS  INSIGHTS

Innovative Routines for Proactive Strategies

NB : INOVIS Inc. is the boutique branch of the global INOVIS group that specializes in creative, tailored, proactive CI services for a select number of InfoTech & MedTech clients. By comparison, INOVIS AG, which focusses on Pharma & Biotech, is a mid-sized agency offering both bespoke CI solutions and proprietary in-house CI tools to a broader client base in the Life Sciences field. Both the Pharma and Tech sides' strict specialty and focus create synergies from each entity's talent pool and experience.

READ MORE INSIGHTS FROM INOVIS

The most shrewd anticipatory and proactive strategies combine several not-so-traditional business practices that work collectively

Build distinct signals from noise systems. Most organizations drown in information but starve for insight. You need dedicated mechanisms to scan for weak signals—not just industry reports everyone reads, but patent filings, academic research, fringe communities, hiring patterns at key companies, regulatory ‘tea leaves’. And don’t forget the qualitative depth of insights gained from Primary Intelligence!

[ PRIMARY INTEL FILLS GAPS ]

Institutionalize dissent and edge perspectives. Bring in people who think the current strategy is wrong—contractors, advisors, even competitors in war games. Create forums where junior employees can challenge senior assumptions without career risk. Reverse mentoring programs and Red Team exercises are 2 examples. Thought Partners can often help facilitate these practices.

[ THOUGHT PARTNERS ]

Run scenario planning workshops with teeth. Not the performative kind that produces binders nobody reads, but exercises that force resource allocation decisions. "If quantum computing breaks current encryption in 3 years, what are we doing differently by next quarter?" If you can't answer that concretely, you're not really planning.

[ WORKSHOPS THAT WORK ]

Separate exploration from exploitation organizationally. Your core business optimizes for efficiency and incremental gains—it should. But you need protected spaces where different metrics apply: speed to learning, not ROI; questions answered, not revenue generated. Amazon's two-pizza teams, Alphabet's X, Pixar's Braintrust model; all great examples.

Develop leading indicators, not just lagging ones. Revenue and market share tell you where you've been. Better metrics might be: time from idea to experiment, percentage of revenue from products that didn't exist two years ago, or even qualitative measures like "are competitors copying us or are we copying them?”

Practice strategic optionality. Make small, reversible moves that preserve multiple futures rather than large, irreversible bets. This is especially powerful in technology—contribute to three emerging standards rather than betting everything on one. Hire for adjacent skills before you need them. Build modular architectures that can pivot.

The hardest part isn't any single practice—it's maintaining them when quarterly pressures mount. Being proactive requires investing in things that don't help this quarter's numbers, which means you need either patient capital or leadership willing to spend credibility protecting those investments.

For over 30 years, INOVIS has been helping companies develop C-Suite savvy, proactive, and actionable competitive strategies. Interested in our process? Let’s Chat!

Since 1992, INOVIS has supported decision-making, implementation and execution across the LIFE SCIENCES and TECHNOLOGIES sectors, leveraging world-class CI and marketing expertise through a network of experienced senior industry leaders who advance strategic thinking and nurture company and brand strategies.

If you think our specialized services might be a great match for your competitive strategy development,

OR, if you are interested in working with a tight-knit, dynamic team [ more info ] ,

Marc Limacher
INOVIS Founder & CEO INOVIS Inc.
CI for Technologies [infotech, fintech,  medtech]
Board Member for INOVIS AG
      

A 30+year veteran in the CI and counter-intelligence industry, Marc Limacher has grown INOVIS into a global leader in primary intelligence and strategic consulting services, serving a select group of global Fortune 100 companies as loyal clients. He is responsible for the overall strategic direction of the firm and manages the operation of the Technologies practice.

Prior to INOVIS, Marc was Director of Market Intelligence at a leading U.S. institutional investment firm for five years, providing primary intelligence on small-/medium-/large-cap life science equities via a global employee network of 125 investigative journalists. He also delivers private CI seminars and is a frequent lecturer on CI and counter-intelligence topics at companies and to academia.